SI0668279T1 - 6-Azaindole thromboxane synthase inhibitors - Google Patents

6-Azaindole thromboxane synthase inhibitors

Info

Publication number
SI0668279T1
SI0668279T1 SI9530517T SI9530517T SI0668279T1 SI 0668279 T1 SI0668279 T1 SI 0668279T1 SI 9530517 T SI9530517 T SI 9530517T SI 9530517 T SI9530517 T SI 9530517T SI 0668279 T1 SI0668279 T1 SI 0668279T1
Authority
SI
Slovenia
Prior art keywords
azaindole
synthase inhibitors
thromboxane synthase
integer
zero
Prior art date
Application number
SI9530517T
Other languages
English (en)
Inventor
Joseph Anthony Jakubowski
Alan David Palkowitz
Sandra Kay Sigmund
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SI0668279T1 publication Critical patent/SI0668279T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI9530517T 1994-01-31 1995-01-30 6-Azaindole thromboxane synthase inhibitors SI0668279T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/189,212 US5468757A (en) 1994-01-31 1994-01-31 6-azaindole thromboxane synthase inhibitors
EP95300551A EP0668279B1 (de) 1994-01-31 1995-01-30 6-Azaindole-Hemmer der Tromboxan-Synthetase

Publications (1)

Publication Number Publication Date
SI0668279T1 true SI0668279T1 (en) 2001-12-31

Family

ID=22696403

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9530517T SI0668279T1 (en) 1994-01-31 1995-01-30 6-Azaindole thromboxane synthase inhibitors

Country Status (11)

Country Link
US (1) US5468757A (de)
EP (1) EP0668279B1 (de)
JP (1) JPH0853448A (de)
AT (1) ATE202103T1 (de)
CA (1) CA2141231A1 (de)
DE (1) DE69521223T2 (de)
DK (1) DK0668279T3 (de)
ES (1) ES2157292T3 (de)
GR (1) GR3036570T3 (de)
PT (1) PT668279E (de)
SI (1) SI0668279T1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5187991B2 (ja) * 1997-10-17 2013-04-24 アーク・セラピューティックス・リミテッド レニン−アンジオテンシン系の阻害剤の使用
WO1999020624A1 (en) 1997-10-20 1999-04-29 F.Hoffmann-La Roche Ag Bicyclic kinase inhibitors
ATE258934T1 (de) 1998-10-30 2004-02-15 Lilly Co Eli Azaindol derivate und ihre verwendung als antithrombotische wirkstoffe
EP1165075A4 (de) * 1999-03-10 2002-04-10 Merck & Co Inc 6-azaindolverbindungen als antagonisten des gonadoliberins
US20040235867A1 (en) * 2001-07-24 2004-11-25 Bilodeau Mark T. Tyrosine kinase inhibitors
GB0330043D0 (en) * 2003-12-24 2004-01-28 Pharmacia Italia Spa Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions comprising them
ATE412651T1 (de) 2004-06-09 2008-11-15 Glaxo Group Ltd Pyrrolopyridinderivate
US20070155738A1 (en) 2005-05-20 2007-07-05 Alantos Pharmaceuticals, Inc. Heterobicyclic metalloprotease inhibitors
EP3801499B1 (de) * 2018-06-07 2024-02-28 Disarm Therapeutics, Inc. Inhibitoren von sarm1
WO2020210649A1 (en) 2019-04-12 2020-10-15 Riboscience Llc Bicyclic heteroaryl derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI75569C (fi) * 1981-06-22 1988-07-11 Ciba Geigy Ag Analogifoerfarande foer framstaellning av terapeutiskt verkande imidazo/1,5-a/pyridiner.
US4588732A (en) * 1982-12-21 1986-05-13 Ciba-Geigy Corporation Certain imidazo(1,5-a)pyridine derivatives and their use as thromboxane synthetase inhibitors
US4470986A (en) * 1982-12-21 1984-09-11 Ciba-Geigy Corporation Certain imidazo (1,5-A) pyridine aliphatic carboxylic acid derivatives and their use as selective thromboxane inhibitors
DE3302125A1 (de) * 1983-01-22 1984-07-26 Boehringer Ingelheim KG, 6507 Ingelheim Aminosaeure-derivate, verfahren zu ihrer herstellung und verwendung
FR2658511B1 (fr) * 1990-02-16 1992-06-19 Union Pharma Scient Appl Nouveaux derives de benzimidazole et d'azabenzimidazole, antagonistes des recepteurs au thromboxane; leurs procedes de preparation, compositions pharmaceutiques les contenant.
ATE173251T1 (de) * 1991-08-21 1998-11-15 Eisai Co Ltd Kondensierte pyrimidinderivate als antitumorverbindungen

Also Published As

Publication number Publication date
EP0668279B1 (de) 2001-06-13
EP0668279A3 (de) 1995-08-30
PT668279E (pt) 2001-09-28
DE69521223T2 (de) 2001-11-08
ES2157292T3 (es) 2001-08-16
DE69521223D1 (de) 2001-07-19
CA2141231A1 (en) 1995-08-01
ATE202103T1 (de) 2001-06-15
EP0668279A2 (de) 1995-08-23
JPH0853448A (ja) 1996-02-27
DK0668279T3 (da) 2001-08-27
US5468757A (en) 1995-11-21
GR3036570T3 (en) 2001-12-31

Similar Documents

Publication Publication Date Title
ES2090790T3 (es) Derivados de glicolipidos.
NO307255B1 (no) Nye forbindelser og antitumormidler
DK0918776T3 (da) Totalsyntese af antitumor acylfulvener
SI0668279T1 (en) 6-Azaindole thromboxane synthase inhibitors
DK0784055T3 (da) Pyrimidinylpyrazolderivater
PT947504E (pt) Derivados de vitamina d 16-eno
ES2188481T3 (es) Derivados de polinalbufina.
ES2169220T3 (es) Derivados de vitamina d3 con sustituyentes en la posicion 2.
EP0538969A3 (de)
DK0601191T3 (da) Hidtil ukendt tetracyklisk forbindelse
NO900732D0 (no) Arylalkylaminforbindelser.
MX9603348A (es) Derivados de disulfuro de amida indano-2-mercaptoacetilica novedosos utiles como inhibidores de encefalinasa.
HU9600996D0 (en) Nitric esters from derivatives of 2-(2,6-dihalophenyl-amino)-phenylacetoxyacetic acid and their preparation procedures
BG103398A (en) New derivatives of erythromicyn, method for their preparation and application as medicmentous forms
SI0681788T1 (en) Dioxabicyclo(3.3.0) octane derivatives, e.g. sesamin etc., for prevention or alleviation of allergy symptoms
ATE217311T1 (de) Cyclopropancyclus enthaltende purinderivate
DK1264836T3 (da) Fremgangsmåde til fremstilling af indolopyrrolocarbaxolderivater
EP0418655A3 (en) Conjugated gamma-hydroxybutenolide compounds and antiulcer agents containing the same as an effective ingredient